Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126660331 | 12666033 | 1 | I | 200808 | 20090304 | 20160818 | 20160818 | PER | US-JAZZ-JPI-P-006566 | JAZZ | 29.98 | YR | M | Y | 79.55000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126660331 | 12666033 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.5 G, BID | U | 21196 | 2.5 | G | ORAL SOLUTION | ||||||
| 126660331 | 12666033 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.5 G, QD | U | 21196 | 3.5 | G | ORAL SOLUTION | ||||||
| 126660331 | 12666033 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, QD | U | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 126660331 | 12666033 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | U | 21196 | 4 | G | ORAL SOLUTION | ||||||
| 126660331 | 12666033 | 5 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | UNK | U | 0 | |||||||||
| 126660331 | 12666033 | 6 | SS | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | UNK | U | 0 | |||||||||
| 126660331 | 12666033 | 7 | C | Ciclesonide | CICLESONIDE | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 126660331 | 12666033 | 8 | C | DEXTROAMPHETAMINE. | DEXTROAMPHETAMINE | 1 | U | 0 | 5 | MG | |||||||||
| 126660331 | 12666033 | 9 | C | DEXTROAMPHETAMINE. | DEXTROAMPHETAMINE | 1 | U | 0 | 5 | MG | |||||||||
| 126660331 | 12666033 | 10 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | U | 0 | 5 | MG | |||||||||
| 126660331 | 12666033 | 11 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | U | 0 | |||||||||||
| 126660331 | 12666033 | 12 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126660331 | 12666033 | 1 | Narcolepsy |
| 126660331 | 12666033 | 5 | Depression |
| 126660331 | 12666033 | 6 | Depression |
| 126660331 | 12666033 | 7 | Asthma |
| 126660331 | 12666033 | 8 | Narcolepsy |
| 126660331 | 12666033 | 10 | Tremor |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126660331 | 12666033 | Amnesia | |
| 126660331 | 12666033 | Blood pressure increased | |
| 126660331 | 12666033 | Depression | |
| 126660331 | 12666033 | Insomnia | |
| 126660331 | 12666033 | Somnolence | |
| 126660331 | 12666033 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126660331 | 12666033 | 1 | 20080822 | 0 | ||
| 126660331 | 12666033 | 2 | 2008 | 0 | ||
| 126660331 | 12666033 | 3 | 2008 | 0 | ||
| 126660331 | 12666033 | 4 | 20100122 | 0 |